Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Amyotrophic lateral sclerosis (ALS) Motor Neuron |
📓
Cyanobacteria, Cyanotoxins, and Neurodegenerative Diseases: Dangerous Liaisons. International journal of molecular sciences (Int J Mol Sci ) Vol: 22 Issue 16 Pages: Pub: 2021 Aug 13 Epub: 2021 Aug 13 Authors Sini P , Dang TBC , Fais M , Galioto M , Padedda BM , Lugliè A , Iaccarino C , Crosio C , Html Article Publication |
| Amyotrophic lateral sclerosis (ALS) Motor Neuron |
📓
The Impact of Microbiota on the Pathogenesis of Amyotrophic Lateral Sclerosis and the Possible Benefits of Polyphenols. An Overview. Metabolites (Metabolites ) Vol: 11 Issue 2 Pages: Pub: 2021 Feb 20 Epub: 2021 Feb 20 Authors Casani-Cubel J , Benlloch M , Sanchis-Sanchis CE , Marin R , Lajara-Romance JM , de la Rubia Orti JE , Html Article Publication |
| Amyotrophic lateral sclerosis (ALS) Motor Neuron |
📓
The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients. Scientific reports (Sci Rep ) Vol: 10 Issue 1 Pages: 12998 Pub: 2020 Aug 3 Epub: 2020 Aug 3 Authors Zeng Q , Shen J , Chen K , Zhou J , Liao Q , Lu K , Yuan J , Bi F , Html Article Publication |
| Amyotrophic lateral sclerosis (ALS) Motor Neuron |
📓
A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis. BMC medicine (BMC Med ) Vol: 18 Issue 1 Pages: 153 Pub: 2020 Jun 17 Epub: 2020 Jun 17 Authors Di Gioia D , Bozzi Cionci N , Baffoni L , Amoruso A , Pane M , Mogna L , Gaggìa F , Lucenti MA , Bersano E , Cantello R , De Marchi F , Mazzini L , Html Article Publication |
| Amyotrophic lateral sclerosis (ALS) Motor Neuron |
📓
Circadian Rhythm Dysfunction Accelerates Disease Progression in a Mouse Model With Amyotrophic Lateral Sclerosis. Frontiers in neurology (Front Neurol ) Vol: 9 Issue Pages: 218 Pub: 2018 Epub: 2018 Apr 24 Authors Huang Z , Liu Q , Peng Y , Dai J , Xie Y , Chen W , Long S , Pei Z , Su H , Yao X , Html Article Publication |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
